NEKTAR THERAPEUTICS Business Operations Contracts & Agreements
8 Contracts & Agreements
- Collaboration Agreements (4 contracts)
- Development Agreements (2)
- Settlement Agreements (1)
- Termination Agreements (1)
- Amendment No. 2 to Strategic Collaboration Agreement dated as of January 12, 2022, by and between Bristol-M (Filed With SEC on March 1, 2022)
- Amendment No. 1 to Strategic Collaboration Agreement dated as of January 9, 2020, by and between Bristol-Myers Squibb and Company and Nektar Therapeutics (Filed With SEC on February 28, 2020)
- CLINICAL TRIAL COLLABORATION AGREEMENT (Filed With SEC on November 4, 2016)
- COLLABORATION AND LICENSE AGREEMENT by and between DAIICHI SANKYO EUROPE GMBH and NEKTAR THERAPEUTICS DATE: May 30, 2016 (Filed With SEC on August 4, 2016)
- TERMINATION AGREEMENT AND MUTUAL RELEASE (Filed With SEC on February 29, 2008)
- EXCLUSIVE RESEARCH, DEVELOPMENT, (Filed With SEC on February 29, 2008)
- SETTLEMENT AGREEMENT AND GENERAL RELEASE (Filed With SEC on August 9, 2006)
- DEVELOPMENT ANDLICENSE AGREEMENT (Filed With SEC on March 14, 2005)
